What is galantamine (ER), and what is it used for?
Galantamine ER (extended-release) is a formulation of galantamine, a medication used to treat Alzheimer’s disease by helping improve or stabilize symptoms related to memory and thinking for some people. ER versions release the drug more slowly over the day than immediate-release options.
How is galantamine ER different from other galantamine forms?
ER (extended-release) galantamine is designed for once-daily dosing, which can make it easier to follow than more frequent dosing schedules. Immediate-release formulations typically require more frequent dosing.
How is galantamine ER usually taken?
Galantamine ER is taken by mouth once daily (timing and food instructions depend on the prescriber’s directions and the specific product label). Like other Alzheimer’s medications, it’s generally started at a low dose and increased gradually based on tolerability.
What side effects do people ask about with galantamine ER?
Common side effects with galantamine products often include gastrointestinal effects such as nausea and diarrhea, plus dizziness. Because it affects the cholinergic system, it can also cause other related effects such as loss of appetite or weight loss in some patients.
What should patients avoid or tell their clinician before starting galantamine ER?
People considering galantamine ER typically need to tell their clinician about other medications they take, especially drugs that can affect heart rate or interact with cholinergic activity. Patients with certain cardiac conditions may need extra caution because cholinergic medicines can affect pulse and conduction.
Is galantamine ER covered by patents and generics?
Galantamine has been on the market for years, and many galantamine products are available as generics or under older approvals. For the most up-to-date patent and exclusivity status tied to specific brand/strength/dosage forms, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/